Tasquinimod Shows Some Activity in Myeloma



(MedPage Today) — In a study presented at the recent American Society of Clinical Oncology (ASCO) annual meeting, investigational tasquinimod showed early activity in relapsed/refractory multiple myeloma, with responses in patients resistant to…



Source link : https://www.medpagetoday.com/meetingcoverage/ascovideopearlsmm/116285

Author :

Publish date : 2025-06-27 15:42:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version